| Bob Woods |
| NPT and Evidence Based Medicine |
 |
What is Evidence Based Medicine? |
|
How many NPI exist? |
|
Are NPI used to their potential? |
|
How can NPI be used rationally? |
|
Possible side effects or overdose of NPI |
|
What role should NPI play in the overall management of dementia? |
|
Are NPI Research Methodologies comparable to Pharmacological Research? |
|
Why is there so little good NPI research available? |
|
How can we improve NPI Research in the future? |
|
More NPI research: possible pay off |
|
|
 |
| |
|
| Miia Kivipelto |
| Physical Exercise |
|
How to reduce the risk of suffering from AD. |
|
Cases Where there is no effective way to prevent the AD. |
|
Risk factors |
|
|
 |
| |
|
| |
|
| Sunnie Kenowski |
| NPT and Politics |
|
Are NPI used appropriately in the US? |
|
How can NPT be rationally integrated in standard dementia care? |
|
|
 |
| |
|
| |
|
| Barry Reisberg |
| Retrogenesis as treatment framework |
|
What is retrogenesis? |
|
How Many typical stages have been identified in AD? |
|
What are the differences between AD patients and children? |
|
What domains are subject to retrogenetic process? |
|
Is there a correspondence to children developmental age? |
|
What needs do children and AD patients share? |
|
How do you envisage AD care? |
|
What is the toughest AD Stage? |
|
Is there a link between symptoms of AD and how the patient was in the past? |
|
|
 |
| |
|
| |
|
| Javier Olazarán |
| Cognitive intervention and staging |
|
In what stages are cognitive interventions appropriate? |
|
Do NPTS make sense for severe dementia? |
|
What is the role of NPTs in dementia care? |
|
Do different stages of the illness require different treatments? |
|
What is the role of love in AD care? |
|
|
 |
| |
|
| |
|
| Cleusa Ferri |
| Racial and continental differences for NPT |
|
Does epidemiology vary over continents or between developed and developing countries? |
|
What is the role of education in Ad? |
|
Do BPSD vary among Continents? |
|
What is the role of NPT in developing countries? |
|
|
 |
| |
|
| |
|
| Howard Feldman |
| Pharmacological treatment |
|
What types of pharmacological treatment are there available? |
|
What is the benefit of AD drugs? |
|
|
 |
| |
|
| |
|
| Rubén Muñiz |
| NPT Project objetives |
|
What is the Objective of NPT Conference? |
|
What is the purpose of NPT? |
|
|
 |
| |
|
| |
|
| Aimee Spector |
| Reminiscence, cognitive stimulation, validation |
|
Types of NPI available |
|
|
 |
| |
|
| |
|
| Mary Mittelman |
| Caregiver interventions |
|
A randomized controled trial on care giver intervention |
|
Short and long term effects |
|
|
 |
| |
|
| |
|
| Jordi Peña-Casanova |
| Combining pharma and non-pharma |
|
What is the relevance of NPI in AD treatment? |
|
|
 |
| |
|
| |
|
